BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nappi A, Perrella A, Rinaldi L, Izzi A, Punzi R, Adinolfi LE, Sbeglia C, Bellopede P, Maddaloni A, Papa N, Spatarella M. Late HCC onset after DAAs therapy in patients with SVR: a type D ADR that requires a longer follow-up? Eur J Hosp Pharm 2019;26:243-4. [PMID: 31338185 DOI: 10.1136/ejhpharm-2019-001975] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Perumalswami PV, Wyatt B, Bowman CA, Patel K, Mageras A, Lewis SC, Branch AD. Hepatocellular carcinoma surveillance, incidence, and tumor doubling times in patients cured of hepatitis C. Cancer Med 2022. [PMID: 35261196 DOI: 10.1002/cam4.4508] [Reference Citation Analysis]